ReviewWorld journal of microbiology & biotechnology2025
Emerging green-synthesized nanozymes for microbial applications: toward sustainable antimicrobial technologies.
Review in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green-synthesized nanozymes represent a transformative approach to microbial control, integrating sustainability with advanced nano-catalytic function. These nanozymes exhibit remarkable enzyme-like activity, including oxidase, peroxidase, and catalase mimetic properties, enabling effective antimicrobial action via reactive oxygen species (ROS) generation, metal ion release, and biofilm disruption. Their synthesis through plant, microbial, algal, and waste-derived methods reduces toxicity and environmental impact while enhancing biocompatibility and cost-effectiveness. Applications in clinical therapies, food and water decontamination, and environmental remediation demonstrate their vast potential. Despite these promising attributes, green nanozymes still face challenges such as inconsistent catalytic efficiency, scalability, and limited substrate specificity. Future innovations must prioritize mechanistic understanding, atomic-level design, and AI-assisted synthesis to improve selectivity and reproducibility. Regulatory clarity and eco-toxicological evaluations will be critical for their clinical and commercial translation. Overall, green-synthesized nanozymes hold the promise to redefine antimicrobial strategies, offering multifunctional, low-carbon solutions aligned with the global sustainability agenda.
Indexed as
Identifiers
41205093What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.